{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T03:43:38Z","timestamp":1776311018204,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1038\/s41372-019-0440-8","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T08:02:59Z","timestamp":1565078579000},"page":"1370-1376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Racial association and pharmacotherapy in neonatal opioid withdrawal syndrome"],"prefix":"10.1038","volume":"39","author":[{"given":"Abhinav","family":"Parikh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathangi","family":"Gopalakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahad","family":"Azeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Booth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"El-Metwally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,6]]},"reference":[{"key":"440_CR1","doi-asserted-by":"publisher","first-page":"e547","DOI":"10.1542\/peds.2013-3524","volume":"134","author":"P Kocherlakota","year":"2014","unstructured":"Kocherlakota P. Neonatal abstinence syndrome. Pediatrics. 2014;134:e547\u201361. https:\/\/doi.org\/10.1542\/peds.2013-3524","journal-title":"Pediatrics"},{"key":"440_CR2","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/jp.2015.36","volume":"35","author":"SW Patrick","year":"2015","unstructured":"Patrick SW, Davis MM, Lehman CU, Cooper WO. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009\u20132012. J Perinatol. 2015;35:650\u20135. https:\/\/doi.org\/10.1038\/jp.2015.36","journal-title":"J Perinatol."},{"key":"440_CR3","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1056\/NEJMsa1500439","volume":"372","author":"V Tolia","year":"2015","unstructured":"Tolia V, Patrick S, Bennett M, Murthy K, Sousa J, Smith B. et al. Increasing Incidence of the neonatal abstinence syndrome in U.S neonatal ICUs. N Engl J Med. 2015;372:2118\u201326. https:\/\/doi.org\/10.1056\/NEJMsa1500439 .","journal-title":"N Engl J Med"},{"key":"440_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1067\/S0002-9378(03)00520-9","volume":"189","author":"V Berghella","year":"2003","unstructured":"Berghella V, Lim PJ, Hill MK, Cherpes J, Chennat J, Kaltenbach K. Maternal methadone dose and neonatal withdrawal. Am J Obstet Gynecol. 2003;189:312\u20137.","journal-title":"Am J Obstet Gynecol"},{"key":"440_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/cpt.159","volume":"98","author":"T Lewis","year":"2015","unstructured":"Lewis T, Dinh J, Leeder JS. Genetic determinants of fetal opiate exposure and risk of neonatal abstinence syndrome: knowledge deficits and prospects for future research. Clin Pharmacol Ther. 2015;98:309\u201320.","journal-title":"Clin Pharmacol Ther"},{"key":"440_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1001\/jamapediatrics.2017.5195","volume":"172","author":"KDL MacMillan","year":"2018","unstructured":"MacMillan KDL, Rendon CP, Verma K, Riblet N, Washer DB, Volpe Holmes A. Association of rooming-in with outcomes for neonatal abstinence syndrome: a systematic review and meta-analysis. JAMA Pediatr. 2018;172:345\u201351. https:\/\/doi.org\/10.1001\/jamapediatrics.2017.5195","journal-title":"JAMA Pediatr"},{"key":"440_CR7","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1056\/NEJMra1600879","volume":"375","author":"K McQueen","year":"2016","unstructured":"McQueen K, Murphy-Oikonen J. Neonatal abstinence syndrome. N Engl J Med. 2016;375:2468\u201379. https:\/\/doi.org\/10.1056\/NEJMra1600879","journal-title":"N Engl J Med"},{"key":"440_CR8","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1080\/17425255.2018.1499726","volume":"14","author":"LW Han","year":"2018","unstructured":"Han LW, Gao C, Mao Q. An update on expression and function of P-gp\/ABCB1 and BCRP\/ABCG2 in the placenta and fetus. Expert Opin Drug Metabol Toxicol. 2018;14:817\u201329.","journal-title":"Expert Opin Drug Metabol Toxicol"},{"key":"440_CR9","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.bcp.2010.06.025","volume":"80","author":"SJ Hemauer","year":"2010","unstructured":"Hemauer SJ, Patrikeeva SL, Wang X, Abdelrahman D, Hankins G, Ahmed M, et al. Role of transporter-mediated efflux in the placental biodisposition of bupropion and its metabolite, OH-bupropion. Biochem Pharmacol. 2010;80:1080\u20136.","journal-title":"Biochem Pharmacol"},{"key":"440_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1067\/mcp.2001.117412","volume":"70","author":"RB Kim","year":"2001","unstructured":"Kim RB, Leake BF, Choo EF, Dresser GK, Kubba SV, Schwarz UI, et al. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther. 2001;70:189\u201399.","journal-title":"Clin Pharmacol Ther"},{"key":"440_CR11","first-page":"481","volume":"13","author":"DL Kroetz","year":"2003","unstructured":"Kroetz DL, Pauli-Magnus C, Hodges LM, Huang CC, Kawamoto M, Johns SJ, et al. Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene. Pharm Genom. 2003;13:481\u201394.","journal-title":"Pharm Genom."},{"key":"440_CR12","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/FTD.0000000000000087","volume":"36","author":"J Lam","year":"2014","unstructured":"Lam J, Koren G. P-glycoprotein in the developing human brain: a review of the effects of ontogeny on the safety of opioids in neonates. Ther Drug Monit. 2014;36:699\u2013705.","journal-title":"Ther Drug Monit"},{"key":"440_CR13","first-page":"154","volume":"7","author":"G Leschziner","year":"2007","unstructured":"Leschziner G, Andrew T, Pirmohamed M, Johnson M. ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research. Pharm J 2007;7:154.","journal-title":"Pharm J"},{"key":"440_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/ajad.12483","volume":"26","author":"EM Wachman","year":"2017","unstructured":"Wachman EM, Hayes MJ, Sherva R, Brown MS, Shrestha H, Logan BA, et al. Association of maternal and infant variants in PNOC and COMT genes with neonatal abstinence syndrome severity. Am J Addict. 2017;26:42\u20139. https:\/\/doi.org\/10.1111\/ajad.12483","journal-title":"Am J Addict"},{"key":"440_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/EDE.0000000000000858","volume":"29","author":"MJ Alexander","year":"2018","unstructured":"Alexander MJ, Kiang MV, Barbieri M. Trends in Black and White Opioid Mortality in the United States, 1979-2015. Epidemiology. 2018;29:707\u201315.","journal-title":"Epidemiology"},{"key":"440_CR16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/15332641003772587","volume":"9","author":"ES Brown","year":"2010","unstructured":"Brown ES, Tirado C, Minhajuddin A, Hillhouse M, Adinoff B, Ling W, et al. Association of race and ethnicity with withdrawal symptoms, attrition, opioid use, and side-effects during buprenorphine therapy. J Ethn Subst Abus. 2010;9:106\u201314.","journal-title":"J Ethn Subst Abus."},{"key":"440_CR17","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.2217\/pgs.13.94","volume":"14","author":"T Fukuda","year":"2013","unstructured":"Fukuda T, Chidambaran V, Mizuno T, Venkatasubramanian R, Ngamprasertwong P, Olbrecht V, et al. OCT1 genetic variants influence the pharmacokinetics of morphine in children. Pharmacogenomics. 2013;14:1141\u201351.","journal-title":"Pharmacogenomics."},{"issue":"2","key":"440_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0740-5472(94)00069-4","volume":"12","author":"Thomas R. Kosten","year":"1995","unstructured":"Kosten, T, Rayford B. Effects of ethnicity on low-dose opiate stabilization. J Subst Abus Treat. 1995;12:111\u20136.","journal-title":"Journal of Substance Abuse Treatment"},{"key":"440_CR19","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.bcp.2009.07.002","volume":"78","author":"SJ Hemauer","year":"2009","unstructured":"Hemauer SJ, Patrikeeva SL, Nanovskaya TN, Hankins GD, Ahmed MS. Opiates inhibit paclitaxel uptake by P-glycoprotein in preparations of human placental inside-out vesicles. Biochem Pharmacol. 2009;78:1272\u20138.","journal-title":"Biochem Pharmacol"},{"key":"440_CR20","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1073\/pnas.97.7.3473","volume":"97","author":"S1 Hoffmeyer","year":"2000","unstructured":"Hoffmeyer S1, Burk O, von Richter O, Arnold HP, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000;97:3473\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"440_CR21","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00439-010-0807-6","volume":"127","author":"DA Nielsen","year":"2010","unstructured":"Nielsen DA, Hamon S, Yuferov V, Jackson C, Ho A, Ott J, et al. Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts. Hum Genet. 2010;127:639\u201349.","journal-title":"Hum Genet."},{"key":"440_CR22","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.2217\/pgs.12.94","volume":"13","author":"DA Nielsen","year":"2012","unstructured":"Nielsen DA, Utrankar A, Reyes JA, Simons DD, Kosten TR. Epigenetics of drug abuse: Predisposition or response. Pharmacogenomics. 2012;13:1149\u201360.","journal-title":"Pharmacogenomics."},{"key":"440_CR23","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/npp.2008.108","volume":"34","author":"DA Nielsen","year":"2009","unstructured":"Nielsen DA, Yuferov V, Hamon S, Jackson C, Ho A, Ott J, et al. Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts. Neuropsychopharmacology. 2009;34:867.","journal-title":"Neuropsychopharmacology"},{"key":"440_CR24","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1001\/jama.2013.3411","volume":"309","author":"E Wachman","year":"2013","unstructured":"Wachman E, Hayes M, Brown M, Paul J, Harvey-Wilkes K, Terrin N, et al. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. J Am Med Assoc. 2013;309:1821\u20137. https:\/\/doi.org\/10.1001\/jama.2013.3411 .","journal-title":"J Am Med Assoc"},{"key":"440_CR25","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jpeds.2014.05.040","volume":"165","author":"EM Wachman","year":"2014","unstructured":"Wachman EM, Hayes MJ, Lester BM, Terrin N, Brown MS, Nielsen DA, et al. Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome. J Pediatr. 2014;165:472\u20138. https:\/\/doi.org\/10.1016\/j.jpeds.2014.05.040","journal-title":"J Pediatr"},{"key":"440_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.drugalcdep.2015.07.001","volume":"155","author":"EM Wachman","year":"2015","unstructured":"Wachman EM, Hayes MJ, Sherva R, Brown MS, Davis JM, Farrer LA, et al. Variations in opioid receptor genes in neonatal abstinence syndrome. Drug Alcohol Depend. 2015;155:253\u20139. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.07.001","journal-title":"Drug Alcohol Depend"},{"key":"440_CR27","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3389\/fped.2017.00176","volume":"5","author":"FS Cole","year":"2017","unstructured":"Cole FS, Wegner DJ, Davis JM. The genomics of neonatal abstinence syndrome. Front Pediatr. 2017;5:176. https:\/\/doi.org\/10.3389\/fped.2017.00176","journal-title":"Front Pediatr."},{"key":"440_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pbb.2013.10.018","volume":"123","author":"RC Crist","year":"2014","unstructured":"Crist RC, Berrettini WH. Pharmacogenetics of OPRM1. Pharmacol Biochem Behav. 2014;123:25\u201333.","journal-title":"Pharmacol Biochem Behav"},{"key":"440_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pain.2012.06.011","volume":"154","author":"A Doehring","year":"2013","unstructured":"Doehring A, Oertel BG, Sittl R, L\u00f6tsch J. Chronic opioid use is associated with increased DNA methylation correlating with increased clinical pain. PAIN\u00ae. 2013;154:15\u201323.","journal-title":"PAIN\u00ae"},{"key":"440_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/AOG.0000000000002054","volume":"130","author":"UM Reddy","year":"2017","unstructured":"Reddy UM, Davis JM, Ren Z, Greene MF. Opioid use in pregnancy, neonatal abstinence syndrome, and childhood outcomes: executive summary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American Congress of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation. Obstet Gynecol. 2017;130:10.","journal-title":"Obstet Gynecol."},{"key":"440_CR31","doi-asserted-by":"publisher","first-page":"E611","DOI":"10.36076\/ppj.2018.6.E611","volume":"21","author":"G Ruano","year":"2018","unstructured":"Ruano G, Kost JA. Fundamental considerations for genetically-guided pain management with opioids based on CYP2D6 and OPRM1 polymorphisms. Pain Physician. 2018;21:E611\u201321.","journal-title":"Pain Physician."},{"key":"440_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1940-0640-9-19","volume":"9","author":"SM Bagley","year":"2014","unstructured":"Bagley SM, Wachman EM, Holland E, Brogly SB. Review of the assessment and management of neonatal abstinence syndrome. Addict Sci Clin Pract. 2014;9:19. https:\/\/doi.org\/10.1186\/1940-0640-9-19","journal-title":"Addict Sci Clin Pract"},{"key":"440_CR33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PeterC Austin","year":"2011","unstructured":"Austin Peter C. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46:399\u2013424.","journal-title":"Multivar Behav Res"},{"key":"440_CR34","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3348\/kjr.2015.16.2.286","volume":"16","author":"Seunghee Baek","year":"2015","unstructured":"Seunghee B, Ho PS, Eugene W, Rang PY, Jung KH. Propensity score matching: a conceptual review for radiology researchers. Korean J Radiol. 2015;16:286.","journal-title":"Korean J Radiol"},{"key":"440_CR35","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1515\/jpm-2012-0288","volume":"41","author":"AB O\u2019Connor","year":"2013","unstructured":"O\u2019Connor AB, O\u2019Brien L, Alto WA. Are there gender related differences in neonatal abstinence syndrome following exposure to buprenorphine during pregnancy? J Perinat Med. 2013;41:621\u20133.","journal-title":"J Perinat Med"},{"key":"440_CR36","doi-asserted-by":"publisher","first-page":"258","DOI":"10.5055\/jom.2011.0067","volume":"7","author":"VM Chorbov","year":"2011","unstructured":"Chorbov VM, Todorov AA, Lynskey MT, Cicero TJ. Elevated levels of DNA methylation at the OPRM1 promoter in blood and sperm from male opioid addicts. J Opioid Manag. 2011;7:258\u201364.","journal-title":"J Opioid Manag."},{"key":"440_CR37","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1023\/B:PHAM.0000029276.21063.0b","volume":"21","author":"C Pauli-Magnus","year":"2004","unstructured":"Pauli-Magnus C, Kroetz DL. Functional implications of genetic polymorphisms in the multidrug resistance gene MDR1 (ABCB1). Pharm Res. 2004;21:904\u201313.","journal-title":"Pharm Res"},{"key":"440_CR38","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2174\/1573400510666140320000928","volume":"10","author":"CJ Mistry","year":"2014","unstructured":"Mistry CJ, Bawor M, Desai D, Marsh DC, Samaan Z. Genetics of Opioid Dependence: A Review of the Genetic Contribution to Opioid Dependence. Curr Psychiatry Rev. 2014;10:156\u201367.","journal-title":"Curr Psychiatry Rev."},{"key":"440_CR39","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1046\/j.1360-0443.2003.00391.x","volume":"98","author":"K Johnson","year":"2003","unstructured":"Johnson K, Greenough A, Gerada C. Maternal drug use and length of neonatal unit stay. Addiction. 2003;98:785\u20139.","journal-title":"Addiction"},{"key":"440_CR40","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ajog.2008.06.088","volume":"199","author":"NS Seligman","year":"2008","unstructured":"Seligman NS, Salva N, Hayes EJ, Dysart KC, Pequignot EC, Baxter JK. Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates. Am J Obstet Gynecol. 2008;199:396\u2013e1.","journal-title":"Am J Obstet Gynecol."},{"key":"440_CR41","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.placenta.2005.05.007","volume":"27","author":"M Sun","year":"2006","unstructured":"Sun M, Kingdom J, Baczyk D, Lye S, Matthews S, Gibb W. Expression of the multidrug resistance P-glycoprotein (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. Placenta 2006;27:602\u20139.","journal-title":"Placenta"},{"key":"440_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-016-0082-1","volume":"11","author":"EJ Liebling","year":"2016","unstructured":"Liebling EJ, Yedinak JL, Green TC, Hadland SE, Clark MA, Marshall BD. Access to substance use treatment among young adults who use prescription opioids non-medically. Subst Abus Treat Prev Policy. 2016;11:38.","journal-title":"Subst Abus Treat Prev Policy"},{"key":"440_CR43","doi-asserted-by":"publisher","first-page":"R963","DOI":"10.1152\/ajpregu.00173.2005","volume":"289","author":"AA Mathias","year":"2005","unstructured":"Mathias AA, Hitti J, Unadkat JD. P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages. Am J Physiol Regul Integr Comp Physiol. 2005;289:R963\u20139.","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"440_CR44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jsat.2018.04.003","volume":"89","author":"VL Short","year":"2018","unstructured":"Short VL, Hand DJ, MacAfee L, Abatemarco DJ, Terplan M. Trends and disparities in receipt of pharmacotherapy among pregnant women in publically funded treatment programs for opioid use disorder in the United States. J Subst Abus Treat. 2018;89:67\u201374.","journal-title":"J Subst Abus Treat."}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41372-019-0440-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41372-019-0440-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41372-019-0440-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T21:35:55Z","timestamp":1695072955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-019-0440-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,6]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["440"],"URL":"https:\/\/doi.org\/10.1038\/s41372-019-0440-8","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,6]]},"assertion":[{"value":"27 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}